Triple Negative Breast Cancer

被引：36
|
作者：
Cetin, Idil [1 ]
Topcul, Mehmet [2 ]
机构：
[1] Istanbul Univ, Fac Sci, Dept Radiobiol, Istanbul, Turkey
[2] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey
来源：
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2014年 / 15卷 / 06期
关键词：
Triple negative breast cancer; poor prognosis; targeted therapy; ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; MOLECULAR SUBTYPES; RISK-FACTORS; STEM-CELLS; PROGNOSTIC VALUE; BASAL; CHEMOTHERAPY; CARCINOMA; SURVIVAL;
D O I：
10.7314/APJCP.2014.15.6.2427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), have a poor prognosis. To overcome therapy limitations of TNBC, various new approaches are needed. This mini-review focuses on discovery of new targets and drugs which might offer new hope for TNBC patients.
引用
收藏
页码：2427 / 2431
页数：5
相关论文
共 50 条
  • [41] What is triple-negative breast cancer?
    Irvin, William J., Jr.
    Carey, Lisa A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2799 - 2805
  • [42] Advanced Triple Negative Breast Cancer in Pregnancy
    Chong, Tze Huat
    Durairaj, Gunaseelan G.
    Hayati, Firdaus
    Azizan, Nornazirah
    Ahmedy, Fatimah
    Rashid, Nor Faezan Abdul
    GAZI MEDICAL JOURNAL, 2020, 31 (04): : 663 - 665
  • [43] Triple negative breast cancer in the era of miRNA
    Sabit, Hussein
    Cevik, Emre
    Tombuloglu, Huseyin
    Abdel-Ghany, Shaimaa
    Tombuloglu, Guzin
    Esteller, Manel
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [44] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [45] Is triple negative a prognostic factor in breast cancer?
    Nishimura, R.
    Arima, N.
    Osako, T.
    Okumura, Y.
    EJC SUPPLEMENTS, 2008, 6 (07): : 87 - 87
  • [46] Chemoimmunotherapy for Triple-Negative Breast Cancer
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2521 - 2521
  • [47] Nanomaterial Technology and Triple Negative Breast Cancer
    Hou, Kai
    Ning, Zeng
    Chen, Hongbo
    Wu, Yiping
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [48] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [49] TARGETED THERAPIES FOR TRIPLE NEGATIVE BREAST CANCER
    Cunliffe, Heather
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 97 - 97
  • [50] FLASH radiotherapy for triple negative breast cancer
    Arrigo, Adrien
    Vanreusel, Verdi
    Brants, Louize
    Hermans, Christophe
    Meijnders, Paul
    Verellen, Dirk
    Poortmans, Philip
    Wouters, An
    Gasparini, Alessia
    Montay-Gruel, Pierre
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5408 - S5410
12345